Skip to main content

MoneyWorks4Me

Oxygenta Pharmaceutical informs about disclosure

27 Sep 2024 Evaluate
Oxygenta Pharmaceutical has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pushpalatha Vustala.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1768.40
Dr. Reddys Labs. 1352.00
Cipla 1382.00
Lupin 2000.75
Zydus Lifesciences 1235.00
View more..